Novilla
Founded 2019 · 13 employees on LinkedIn · 1 known investors
Novilla develops localized medicines designed with proprietary chemical-thermodynamics machine learning algorithms, delivering drugs that act at the site of disease while minimizing systemic exposure and side effects. The company focuses on pain therapeutics, aiming to provide effective treatments without the addiction risks associated with opioids.
Founders & leadership
Novilla was founded in 2019 by Dr. Shashi Kori, Ajay Kori, Shashidhar Kori, and Eric Fossel.
DS
Dr. Shashi Kori
AK
Ajay KoriFounder
SK
Shashidhar KoriCo-founder
EF
Eric FosselCo-founder
DT
Dr. Tracey Rapp
Investors · 1
Competitors · 2
by search overlap
IQVIA9 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Bionpharma8 shared keywords
Companies competing with Novilla for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Novilla do?
- Novilla develops localized medicines designed with proprietary chemical-thermodynamics machine learning algorithms, delivering drugs that act at the site of disease while minimizing systemic exposure and side effects. The company focuses on pain therapeutics, aiming to provide effective treatments without the addiction risks associated with opioids.
- Who founded Novilla?
- Novilla was founded by Dr. Shashi Kori, Ajay Kori, Shashidhar Kori, Eric Fossel in 2019.
- Who are Novilla's investors?
- Novilla's investors include Blindspot Ventures Management Co.